BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11215490)

  • 1. [A case of hookworm infestation with dissociation values between FDP-E and FDP-D dimer].
    Nakagoshi R; Oguchi H; Ishii E; Ishikawa S; Higuchi Y; Muramatsu K; Okumura N; Ogiso Y
    Rinsho Byori; 2001 Jan; 49(1):82-6. PubMed ID: 11215490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on cases of D dimer values were dissociated from FDP-E].
    Himizu M; Ishii K; Katagiri H; Saga K; Ono F; Yamamoto M; Todoroki T; Kawai Y; Watanabe K; Iri H
    Rinsho Byori; 1991 Mar; 39(3):302-8. PubMed ID: 2051606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistent discrepancy between FDP and D-dimer in a patient with acute leukemia].
    Sato N; Takahashi H; Nikuni K; Seki Y; Wada K; Tatewaki W; Shibata A
    Rinsho Ketsueki; 1995 Mar; 36(3):212-7. PubMed ID: 7783324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the fragments of FDP in 4 patients with DIC].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Oct; 40(10):1089-95. PubMed ID: 1307614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.
    Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayasaki J; Hayakawa M
    Clin Lab; 2018 Apr; 64(4):433-442. PubMed ID: 29739066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the fragments of FDP in 3 non-DIC patients with increased FDP levels in the sera].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Shinoda T; Nakahata T; Saitoh H
    Rinsho Byori; 1993 Feb; 41(2):220-6. PubMed ID: 8361025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z; Dyr IE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinogen/fibrin degradation products and D-dimer in clinical practice: interpretation of discrepant results.
    Sato N; Takahashi H; Shibata A
    Am J Hematol; 1995 Mar; 48(3):168-74. PubMed ID: 7864025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of antibody reactivity for FDP D-dimer fragments by Western blotting].
    Wakabayashi S; Ishikawa S; Hirota-Kawadobora M; Fujihara N; Kamijyo Y; Yamauchi K; Terasawa F; Okumura N; Katsuyama T
    Rinsho Byori; 2008 Jun; 56(6):449-54. PubMed ID: 18646629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB; Panchenko NI
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum FDP and plasma D-dimer testing: what are they measuring?
    Southern DK
    Clin Lab Sci; 1992; 5(6):332-3. PubMed ID: 10148098
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relation between fibrin/fibrinogen degradation products in malignant fluids and the fibrinolytic activity of the peritoneum].
    Takahashi M; Yoshida K; Kano K; Machida T; Nakamura Y; Miura Y; Miura N; Kanno S
    Gan No Rinsho; 1986 Dec; 32(15):1945-9. PubMed ID: 3806965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA; Ignashenkova GV; Kitaev MI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of fibrinogen-fibrin degradation factors in neoplasms].
    Petrella V; Massara G; Parachini F; Silvera F; Cantone R
    Minerva Med; 1988 Feb; 79(2):117-21. PubMed ID: 3352945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.